Editor’s Note: Badawy AM, Elnashar AM, and Mosbah AA. Aromatase inhibitors or gonadotropin‐releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica, 2012;91:489–495

Acta obstetricia et gynecologica Scandinavica · 2021 · vol. 100(11) , pp. 2125 · doi:10.1111/aogs.14192 · PMID:34160064 · W4200254735
erratum OA: bronze CC0
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-14 ⓘ

This randomized controlled trial compared the efficacy of aromatase inhibitors versus gonadotropin-releasing hormone agonists for managing uterine adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

adenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (1)

Source provenance

europepmc
last seen: 2026-09-11T06:15:56.568227+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:24:31.988741+00:00
License: CC0 · commercial use OK